19 Aug. 2025

Lab Manager at the Cancer Dormancy & Immunity Lab

Research
Application Starts: 19 Aug. 2025

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Lab Manager to join our team at the Champalimaud Research Program. 

The Cancer Dormancy & Immunity Lab, led by Dr. Ana Luisa Correia, at Champalimaud Foundation, Lisbon, Portugal, invites applications for the position of Lab Manager.

16 August 2025

Artificial intelligence can help in the non-invasive diagnosis of prostate cancer

An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging (MRI) scans – that is, without resorting to a biopsy. Their findings were published today, 15th of August, in the journal Radiology: Imaging Cancer.

11 August 2025

First patient included marks major milestone in EU-funded clinical trial

“This is a historic step,” says Prof. Dr. Robert Schoevers, head of psychiatry at the University Medical Center Groningen (UMCG) and principal investigator of PsyPal. “After many months of preparation, we are thrilled to begin working directly with patients.”

Maria João Cardoso

04 Aug. 2025

Physiotherapist

Research
Application Starts: 04 Aug. 2025

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Physiotherapist.

04 Aug. 2025

Research Technician

Research
Application Starts: 04 Aug. 2025

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Research Technician.

Inês Faria

Gleb Gorodetskiy

Cátia Ramos

Psychedelic Therapy: From Evidence to Equity

This one-day event will bring together clinicians, researchers, patient representatives, policymakers and ethicists to explore the landscape of psychedelic-assisted care through the lens of the four pillars of medical ethics: beneficence, autonomy, non-maleficence, and justice.

The symposium will delve into safety, regulation, therapeutic practices, and future directions to ensure equitable access to psychedelic-assisted care.

Subscribe to Champalimaud Research
Loading
Please wait...